www.imugene.com ASX: IMU QUARTERLY ACTIVITIES & APPENDIX 4C CASH REPORT Quarter Ended: 3 0 June 2026 Imugene Limited ABN 99 009 179 551 IMUGENE LIMITED ACN 009 179 551 WWW.IMUGENE.COM info@imugene.com ASX...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Imugene
- Third response in concurrent BTKi Cohort of azer-cel Trial
- $11.1 Million Placement Completed to Advance azer-cel
- New Complete Response in the Concurrent BTKi azer-cel Cohort
- First Complete Response in Concurrent BTKi azer-cel Cohort
- Azer-cel Granted FDA Fast Track Designation for CLL and MZL
Later from Imugene
- Notification of cessation of securities - IMU
- Final Director's Interest Notice - LC
- Expiry Of Listed Options
- Letter To Shareholders
- Results of Extraordinary General Meeting
Follow Imugene into a list and get an email when it puts out news.
Follow Imugene